Group Leader/s
intro
The dynamism and plasticity of energy metabolism is key to cellular homeostasis. Changes in metabolic processes are essential for a correct cellular function but also the basis of several pathologies. Its high relevance as a pharmacological target has emerged as a biomedical discipline in the intervention not only in chronic metabolic diseases but also in the potential correction of metabolic anomalies that are in the etiology of oncological and infectious diseases. The group focuses its research on the characterization of alterations in cellular energy metabolism due to infections, particularly by Leishmania parasites, and pathologies such as cancer. The signalling pathways involved are analyzed to identify new drug targets, working on the design and characterization of new molecules, as well as on the repositioning of existing drugs. The group also investigates the use of the energy metabolism of Leishmania as a pharmacological target, a pathogen in which the group has a long research trajectory.
Members
| Eduardo Rial Zueco |
| Luis Ignacio Rivas López |
| José María Sánchez-Puelles González-Carvajal |
| Paula Martinez de Iturrate Sanz |
| Teresa Perez Blanco |
| Alba García Gomez |
Selected Publications
Lima, M.L., Abengózar, M.A., Nácher-Vázquez, M., Martínez-Alcázar, M.P., Barbas, C., Tempone, A.G., López-Gonzálvez. A., Rivas, L. [2018]. Drug repurposing for Leishmania. Molecular basis of the leishmanicidal activity of the antidepressant sertraline. Antimicrobial Agents and Chemotheraphy. DOI: 10.1128/AAC.01928-18
Rivas, L., Nácher-Vázquez, M., Andreu, D. [2018]. Chapter 13: The Physical Matrix of the Plasma Membrane as a Target: The Charm of Drugs with Low Specificity. RSC Drug Discovery Series. 2018-January:248-281.
Martín-Sánchez, F., Martínez-García, J.J., Muñoz-García, M., Martínez-Villanueva, M., Noguera-Velasco, J.A., Andreu, D., Rivas, L., Pelegrín, P. [2017]. Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release. Cell death & disease. 8:e2984-.
Abengózar, M.A., Cebrián, R., Saugar, J.M., Gárate, T., Valdivia, E., Martínez-Bueno, M., Maqueda, M., Rivas, L. [2017]. Enterocin AS-48 as evidence for the use of bacteriocins as new leishmanicidal agents. Antimicrobial Agents and Chemotherapy. 61:-.
Contreras, L., Rial, E., Cerdan, S., Satrustegui, J. [2017]. Uncoupling Protein 2 (UCP2) Function in the Brain as Revealed by the Cerebral Metabolism of (1–13C)-Glucose. Neurochemical Research. 42:108-114.
Rodríguez-Sánchez, L., Rial, E. [2017]. The distinct bioenergetic properties of the human UCP1. Biochimie. 134:51-55.
Nicholls, D.G., Rial, E. [2016]. A novel regulatory mechanism for the brown-fat uncoupling protein?. Nature Structural and Molecular Biology. 23:364-365.
Fernandez-Prada, C., Vincent, I.M., Brotherton, M.-C., Roberts, M., Roy, G., Rivas, L., Leprohon, P., Smith, T.K., Ouellette, M. [2016]. Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms. PLoS Neglected Tropical Diseases. 10:-.
Doménech, E., Maestre, C., Esteban-Martínez, L., Partida, D., Pascual, R., Fernández-Miranda, G., Seco, E., Campos-Olivas, R., Pérez, M., Megias, D., Allen, K., López, M., Saha, A.K., Velasco, G., Rial, E., Méndez, R., Boya, P., Salazar-Roa, M., Malumbres, M. [2015]. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nature Cell Biology. 17:1304-1316.
Moreira, D., Rodrigues, V., Abengozar, M., Rivas, L., Rial, E., Laforge, M., Li, X., Foretz, M., Viollet, B., Estaquier, J., Cordeiro da Silva, A., Silvestre, R. [2015]. Leishmania infantum Modulates Host Macrophage Mitochondrial Metabolism by Hijacking the SIRT1-AMPK Axis. PLoS Pathogens. 11:1-24.
Funding
“Energy metabolism in the leishmania-macrophage interface: rationale for therapy intervention” Spanish Ministry of Science and Innovation (PID2019-108166GB-I00) (cofunded FEDER)
“Warburg rewiring triggered by coronavirus infection in the host cell: strategy for drug intervention” CSIC PTI Global Health (CSIC-COV19-110) (cofunded FEDER)
“Cooperative Research Network on Tropical Diseases (RICET)” Carlos III Health Institute (RETICS 2016 - RD16/0027/0010) (cofunded FEDER)
“Redox Biology and Medicine Research Network” Spanish Ministry of Science and Innovation (Red2018‐102576‐T) (cofunded FEDER)
“Bioenergetics characterization of human granulosa cells” Instituto Valenciano de Infertilidad (Madrid, Spain)
“Optimization of the therapeutic potential of leishmania protein kinases (PKs). Discovery of specific inhibitory drugs of the parasite PKs”. Spanish Ministry of Science and Innovation (SAF2015-65740-R) (cofunded FEDER)
“New electroanalytical multiplexing platforms for the detection and prognosis of neoplastic diseases by means of liquid biopsies” Spanish Ministry of Science and Innovation (CTQ2015-64402-C2-2-R) (cofunded FEDER)
More info
Recent Ph.D. Thesis
Daniela Saraiva Correa. Study of the bioenergetic alterations induced by synthetic compounds in Leishmania spp,Sao Paolo State University August, 2014. Co-supervised with Prof. André Gustavo Tempone.
María Fernández-Reyes Silvestre. Molecular basis for the activity and resistance of membrane-active peptides in prokaryotes. Their comparison with Leishmania as eukaryotic model Complutense University of Madrid June 2010.
Juan Román Luque-Ortega. The energetic metabolisms in Leishmania as target for new leishmanicidal molecules . Complutense University of Madrid . June 2008
.